It was about 8:30 p.m. on a winter night in Indianapolis when a powerful idea struck Brandon Oberlin, PhDopens in new window. The addiction researcher and associate professor of psychiatry at Indiana University had come across a studyopens in new window at Stanford University showing that when people used virtual reality to interact with renderings of their future selves, they were more likely to delay immediate monetary rewards and accept later ones. In other words, they were more motivated to save money when their future selves felt more real.
Oberlin began pacing. “What if I did this with people in early recovery? Has that been done? Could it be done?” He remembered thinking. “It really was like one of those late-night-in-the-lab eureka moments.”
Turns out, it hadn’t been done and, Oberlin learned, could be done. Over the next 6 or so months, he partnered with local developers to create a virtual reality technology that introduces people in early recovery to two selves 15 years down the line—one who continued using drugs and/or alcohol (“my husband left me, I got another DUI”) and one who has stuck with sobriety (“life is good, I got that degree”). The avatars’ programming is all based on participants’ real experiences and aspirations. “It’s not scolding; it’s just telling you: Hey, this is reality,” Oberlin said.
The intervention—which later sends participants daily photo reminders of their recovered future selves—increases future-self continuity and doubles the ability to delay rewards, his 2022 pilot studyopens in new window showed. Eighteen of the 21 original participants remained abstinent 30 days later, too. “I don’t listen to the police. I don’t listen to my probation officer. I don’t listen to counselors. I don’t listen to anyone else on the street,” one participant told Oberlin after the simulation. “The only one I trust is me, but you’ve got me giving me good advice. I can hear that.” Put another way, the patient experienced a strong therapeutic alliance with his best self.
Since then, Oberlin’s team’s work has spun into a startup called Relate XRopens in new window, which is currently in clinical trialsopens in new window. While starting a business as a lab scientist has had its challenges, Oberlin and other psychology researchers and clinicians encourage their colleagues to embrace VR as a tool for an ever-expanding repertoire of therapeutic applications. “The only limits to this is that of our imaginations—and our clinical acumen,” said Albert “Skip” Rizzo, PhD,opens in new window a research psychologist at the University of Southern California, where he directs the Medical Virtual Reality program.


